Treatment of pulmonary tuberculosis.
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007612:Kanamycin / Q000009:adverse effects; D011718:Pyrazinamide / Q000009:adverse effects; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000601:surgery; D014756:Viomycin / Q000009:adverse effects
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D007612:Kanamycin; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin